Title : Synergistic Anti-Tumour Effect of Syk Inhibitor and Olaparib in Squamous Cell Carcinoma: Roles of Syk in EGFR Signalling and PARP1 Activation.

Pub. Date : 2020 Feb 19

PMID : 32093123






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Notably, both Syk and EGFR inhibitors could induce PARP activation, and synergistic cytotoxic actions were observed in SCC cells upon the combined treatment of the PARP1 inhibitor olaparib with Syk or the EGFR inhibitor. olaparib epidermal growth factor receptor Homo sapiens
2 Notably, both Syk and EGFR inhibitors could induce PARP activation, and synergistic cytotoxic actions were observed in SCC cells upon the combined treatment of the PARP1 inhibitor olaparib with Syk or the EGFR inhibitor. olaparib epidermal growth factor receptor Homo sapiens